张宝腾,翟亚楠,向晓睿,袁志发,郭顺林.基于钆塞酸二钠MRI评价肝纤维化研究进展[J].中国医学影像技术,2021,37(9):1427~1430 |
基于钆塞酸二钠MRI评价肝纤维化研究进展 |
Research progresses of MRI evaluation on hepatic fibrosis based on Gd-EOB-DTPA |
投稿时间:2020-06-11 修订日期:2021-05-31 |
DOI:10.13929/j.issn.1003-3289.2021.09.037 |
中文关键词: 肝硬化 磁共振成像 对比剂 影像组学 深度学习 |
英文关键词:liver cirrhosis magnetic resonance imaging contrast media radiomics deep learning |
基金项目: |
|
摘要点击次数: 1084 |
全文下载次数: 283 |
中文摘要: |
钆塞酸二钠(Gd-EOB-DTPA)是肝细胞特异性对比剂,广泛用于肝胆系统MRI。本文针对基于Gd-EOB-DTPA增强MRI的肝胆期信号强度、灌注参数、T1 mapping、影像组学和深度学习评价肝纤维化程度研究进展进行综述。 |
英文摘要: |
Gd-EOB-DTPA is a hepatocyte-specific contrast agent, which has been widely used in MRI of hepatobiliary system. The research progresses of evaluating the degree of hepatic fibrosis based on Gd-EOB-DTPA enhanced MRI, including hepatobiliary phase signal intensities, perfusion parameters, T1 mapping, radiomics and deep learning were reviewed in this article. |
查看全文 查看/发表评论 下载PDF阅读器 |